BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.700
0.00 (0.00%)
At close: Dec 18, 2025
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
1.51M ILS
Profits / Employee
-352.04K ILS
Market Cap
44.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -51 | -64.56% |
| Dec 31, 2023 | 79 | 30 | 61.22% |
| Dec 31, 2022 | 49 | 11 | 28.95% |
| Dec 31, 2021 | 38 | 0 | - |
| Dec 31, 2020 | 38 | -4 | -9.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 35,686 |
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| InterCure | 320 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
BioLineRx News
- 27 days ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 27 days ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 27 days ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 27 days ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 27 days ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 4 weeks ago - BioLine Rx's Earnings: A Preview - Benzinga
- 4 weeks ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha